Clinical Report: Asthma and Glioma Risk in a Universal Healthcare Population

Overview

This case-control study within the Department of War’s Military Health System found an inverse association between asthma and malignant glioma risk when using MRI-negative controls, suggesting asthma may confer some protective effect. The study minimized recall and detection biases by using medical records for asthma diagnosis and matched controls with similar healthcare access.

Background

Malignant gliomas are the most common and deadly brain tumors with poorly understood etiology aside from genetic factors and ionizing radiation. Asthma, characterized by airway inflammation and hyperactivity, has been epidemiologically linked to a reduced risk of glioma, potentially due to heightened immune responses involving IgE antibodies. Previous studies were limited by self-reported asthma data and detection bias, which this study aimed to overcome by using objective medical records and carefully selected control groups within a universal healthcare setting.

Data Highlights

Key Findings

• An inverse association between asthma and malignant glioma was observed when using MRI-negative controls, but not with community controls.
• Use of medical records for asthma diagnosis reduced recall bias compared to self-reported asthma history.
• Matching controls by MRI status helped reduce detection bias by ensuring similar healthcare access and diagnostic scrutiny.
• The study population included over 9.5 million beneficiaries with universal healthcare access, enhancing generalizability.
• Analysis considered tumor size and timing between asthma and glioma diagnosis to assess detection bias effects.

Clinical Implications

Clinicians should consider that asthma may be associated with a reduced risk of malignant glioma, potentially due to immune mechanisms. Accurate medical record-based asthma diagnosis and awareness of detection bias are important in epidemiologic assessments. Universal healthcare settings provide valuable data to clarify such associations by minimizing access-related confounding.

Conclusion

This robust case-control study supports an inverse relationship between asthma and malignant glioma risk when accounting for detection bias and using objective asthma diagnoses. These findings contribute to understanding glioma etiology and highlight the importance of methodological rigor in epidemiological research.

References

1. Kaur et al. 2021 -- Asthma and Glioma: Addressing Bias in Case-Control Studies
2. Department of War Central Cancer Registry and Military Health System Data Repository
3. National Cancer Institute 2025 -- Brain Tumor Statistics